Your browser doesn't support javascript.
loading
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention]. / Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021.
Brotons, C; Camafort, M; Del Mar Castellanos, M; Clarà, A; Cortés, O; Diaz Rodriguez, A; Elosua, R; Gorostidi, M; Hernández, A M; Herranz, M; Justo, S; Lahoz, C; Niño, P; Pallarés-Carratalá, V; Pedro-Botet, J; Pérez Pérez, A; Royo-Bordonada, M A; Santamaria, R; Tresserras, R; Zamora, A; Zuza, I; Armario, P.
Afiliação
  • Brotons C; Sociedad Española de Medicina de Familia y Comunitaria-semFYC, Barcelona, España. Electronic address: cbrotons@eapsardenya.cat.
  • Camafort M; Sociedad Española de Medicina Interna, Barcelona, España.
  • Del Mar Castellanos M; Sociedad Española de Neurología, Barcelona, España.
  • Clarà A; Sociedad Española de Angiología y Cirugía Vascular, Madrid, España.
  • Cortés O; Asociación Española Pediatría de Atención Primaria, Madrid, España.
  • Diaz Rodriguez A; Sociedad Española de Médicos de Atención Primaria-SEMERGEN, Madrid, España.
  • Elosua R; Sociedad Española de Epidemiología, Barcelona, España.
  • Gorostidi M; Sociedad Española de Nefrología, Santander, España.
  • Hernández AM; Sociedad Española de Diabetes, Madrid, España.
  • Herranz M; Federación de Asociaciones de Enfermería Comunitaria y Atención Primaria-FAECAP, Madrid, España.
  • Justo S; Ministerio de Sanidad, Madrid, España.
  • Lahoz C; Sociedad Española de Medicina Interna, Barcelona, España.
  • Niño P; Sociedad Española de Medicina y Seguridad del Trabajo, España.
  • Pallarés-Carratalá V; Sociedad Española de Médicos de Atención Primaria-SEMERGEN, Madrid, España.
  • Pedro-Botet J; Sociedad Española de Arteriosclerosis, Barcelona, España.
  • Pérez Pérez A; Sociedad Española de Diabetes, Madrid, España.
  • Royo-Bordonada MA; Instituto de Salud Carlos III, Madrid. España.
  • Santamaria R; Sociedad Española de Nefrología, Santander, España.
  • Tresserras R; Sociedad Española de Salud Pública y Administración Sanitaria-SESPAS, Barcelona, España.
  • Zamora A; Sociedad Española de Arteriosclerosis, Barcelona, España.
  • Zuza I; Ministerio de Sanidad, Madrid, España.
  • Armario P; Sociedad Española-Liga Española para la Lucha contra la Hipertensión Arterial, Madrid, España.
Hipertens Riesgo Vasc ; 39(2): 69-78, 2022.
Article em Es | MEDLINE | ID: mdl-35331672
ABSTRACT
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. We present the Spanish adaptation of the 2021 European Guidelines on Cardiovascular Disease (CVD) prevention in clinical practice. The current guidelines besides the individual approach greatly emphasize on the importance of population level approaches to the prevention of cardiovascular diseases. Systematic global CVD risk assessment is recommended in individuals with any major vascular risk factor. Regarding LDL-Cholesterol, blood pressure, and glycemic control in patients with diabetes mellitus, goals and targets remain as recommended in previous guidelines. However, it is proposed a new, stepwise approach (Step 1 and 2) to treatment intensification as a tool to help physicians and patients pursue these targets in a way that fits patient profile. After Step 1, considering proceeding to the intensified goals of Step 2 is mandatory, and this intensification will be based on 10-year CVD risk, lifetime CVD risk and treatment benefit, comorbidities and patient preferences. The updated SCORE algorithm-SCORE2, SCORE-OP- is recommended in these guidelines, which estimates an individual's 10-year risk of fatal and non-fatal CVD events (myocardial infarction, stroke) in healthy men and women aged 40-89 years. Another new and important recommendation is the use of different categories of risk according different age groups (< 50, 50-69 ≥ 70 years). Different flow charts of CVD risk and risk factor treatment in apparently healthy persons, in patients with established atherosclerotic CVD, and in diabetic patients are recommended. Patients with chronic kidney disease are considered high risk or very high-risk patients according to the levels of glomerular filtration rate and albumin-to-creatinine ratio. New lifestyle recommendations adapted to the ones published by the Spanish Ministry of Health as well as recommendations focused on the management of lipids, blood pressure, diabetes and chronic renal failure are included.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Female / Humans / Male Idioma: Es Revista: Hipertens Riesgo Vasc Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Female / Humans / Male Idioma: Es Revista: Hipertens Riesgo Vasc Ano de publicação: 2022 Tipo de documento: Article